Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Omega Therapeutics Inc OMGA

Full chart Compare
Set alert

Price alert · OMGA

All alert types
0.14 USD 0.00 (+0.00%)

At closeFeb 24, 2025, 4:00 PM EST

0.1426 Day range 0.166
0.75 52-week range 6.30
YTD
0.00%
1 year
0.00%

Financial health

Altman Z-Score

-4.95 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

4 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -1.7×
FY 2019: -41.0×FY 2020: -25.4×FY 2021: -7.8×FY 2022: -2.7×FY 2023: -1.7×
FY 2019 5y median -7.8× FY 2023
P/S 52.5×
FY 2019: 0.0×FY 2020: 0.0×FY 2021: 3760×FY 2022: 132×FY 2023: 52.5×
FY 2019 5y median 52.5× FY 2023
P/B 2.8×
FY 2019: -21.3×FY 2020: -11.8×FY 2021: 2.7×FY 2022: 2.6×FY 2023: 2.8×
FY 2019 5y median 2.6× FY 2023
P/FCF -1.7×
FY 2019: -46.2×FY 2020: -27.4×FY 2021: -9.2×FY 2022: -2.7×FY 2023: -1.7×
FY 2019 5y median -9.2× FY 2023
EV/EBITDA -2.4×
FY 2019: -46.8×FY 2020: -27.4×FY 2021: -5.8×FY 2022: -2.3×FY 2023: -2.4×
FY 2019 5y median -5.8× FY 2023
EV/Sales 71.9×
FY 2019: 0.0×FY 2020: 0.0×FY 2021: 2603×FY 2022: 109×FY 2023: 71.9×
FY 2019 5y median 71.9× FY 2023
FCF Yield -58.1%
FY 2019: -2.2%FY 2020: -3.7%FY 2021: -10.9%FY 2022: -36.5%FY 2023: -58.1%
FY 2019 5y median -10.9% FY 2023

Profitability

Gross Margin -2028.9%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: -863.2%FY 2022: -150.4%FY 2023: -2028.9%
FY 2019 5y median -150.4% FY 2023
Operating Margin -3240.5%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: -45855.6%FY 2022: -4957.4%FY 2023: -3240.5%
FY 2019 5y median -3240.5% FY 2023
Net Margin -3148.9%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: -48029.2%FY 2022: -4951.1%FY 2023: -3148.9%
FY 2019 5y median -3148.9% FY 2023
ROE -167.9%
FY 2019: 51.6%FY 2020: 46.7%FY 2021: -34.5%FY 2022: -96.9%FY 2023: -167.9%
FY 2019 5y median -34.5% FY 2023
ROIC -52.0%
FY 2019: -445.4%FY 2020: -122.5%FY 2021: -29.8%FY 2022: -78.8%FY 2023: -52.0%
FY 2019 5y median -78.8% FY 2023
ROA -47.7%
FY 2019: -302.8%FY 2020: -107.5%FY 2021: -29.6%FY 2022: -70.3%FY 2023: -47.7%
FY 2019 5y median -70.3% FY 2023

Growth (YoY)

Revenue 49.3%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 1339.6%FY 2023: 49.3%
FY 2019 FY 2023
Operating Income 2.4%
FY 2019: 0.0%FY 2020: -65.2%FY 2021: -130.5%FY 2022: -55.6%FY 2023: 2.4%
FY 2019 FY 2023
EPS (diluted) 15.9%
FY 2019: 0.0%FY 2020: -61.5%FY 2021: -130.2%FY 2022: -47.6%FY 2023: 15.9%
FY 2019 FY 2023
Free Cash Flow 5.5%
FY 2019: 0.0%FY 2020: -68.7%FY 2021: -111.4%FY 2022: -69.1%FY 2023: 5.5%
FY 2019 FY 2023

Financial Health

Current Ratio 3.4×
FY 2019: 1.2×FY 2020: 3.1×FY 2021: 19.1×FY 2022: 5.7×FY 2023: 3.4×
FY 2019 5y median 3.4× FY 2023
Quick Ratio 3.3×
FY 2019: 1.2×FY 2020: 3.1×FY 2021: 19.1×FY 2022: 3.8×FY 2023: 3.3×
FY 2019 5y median 3.3× FY 2023
Debt / Equity 2.2×
FY 2019: -0.3×FY 2020: -0.2×FY 2021: 0.1×FY 2022: 0.2×FY 2023: 2.2×
FY 2019 5y median 0.1× FY 2023
Net Debt / EBITDA -0.6×
FY 2019: -0.6×FY 2020: 0.4×FY 2021: 2.6×FY 2022: 0.5×FY 2023: -0.6×
FY 2019 5y median 0.4× FY 2023
Interest Coverage 0.0×
FY 2019: -29.1×FY 2020: -36.9×FY 2021: -72.6×FY 2022: 0.0×FY 2023: 0.0×
FY 2019 5y median -29.1× FY 2023

Dividends

Dividend Yield 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%
FY 2019 5y median 0.0% FY 2023
Payout Ratio 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%
FY 2019 5y median 0.0% FY 2023

Annual · latest fiscal year ends 2023-12-31